New study links fertility problems in women to higher risk for heart disease
A new study suggests that women who experience difficulty getting pregnant have a higher risk of havin heart disease later on in life. According to the study, women who do not get pregnant within five years but who eventually get pregnant is 19% more prone to have a heart problem compared to those who got pregnant without any problems.
The proponents want to be clear though that it is still unclear how subfertility makes one more prone to cardiovascular problems. It still needs to be established what in subfertility makes women more prone to cardiac problems.
The researchers looked into the causes of a long road to pregnancy and factor in thyroid problems, obesity, and menstrual period irregularities. Women who have polycystic ovaries also tend to develop high cholesterol levels, hypertension, and increased level of blood sugar which are all contributing factors to heart problems.
The experts also looked into previous studies on subfertility and its connection to heart disease done previously. One study done to more than 860,000 women in Sweden between the early 1980’s thru 2005 looked into subfertility and heart disease in these women who might have been hospitalized or had a stroke, heart failure, or heart attack.
In the previous study, about 3,300 subjects ended up having heart problems. The number of heart disease cases on this population of subjects was also higher on those who encountered difficulty getting pregnant compared to those who did not have fertility problems.
The study was also able to conclude that subfertile women who got pregnant in 4 years or even less are not more prone to heart diseases. The higher risk is not that significant but the researchers suggest that women should seek consult and have regular checkups.

People suffering from depression for quite some time may actually benefit from receiving talk therapy when treatment like antidepressants is not working.
Another chemotherapy drug which helps treat breast cancer in its advanced stages was made recently from sea sponge. According to reports, this drug helped extend the lives of women who are suffering from metastatic breast cancer up to two and a half months. The drug, known as erubulin, was presented during the recent meeting of the American Society of Clinical Oncology which was held in Chicago.


